Haemopoietic stem-cell transplantation: Improving immune reconstitution, avoiding graft-versus-host disease

Lancet

Volumn 360, Issue 9327, 2002, Pages 98-99

  Dickinson, Anne ^a   Cant, Andrew ^b  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOTOXIN; INTERLEUKIN 2 RECEPTOR;

ALLOIMMUNITY; DRUG EFFECT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; IMMUNE RESPONSE; MONONUCLEAR CELL; MORBIDITY; NOTE; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL; T LYMPHOCYTE; VIRUS INFECTION;

EID: 0037072069     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)09431-X     Document Type: Note

References (11)

1. The history and future of T cell depletion as graft versus host disease prophylaxis for allogeneic hematopoietic stem cell transplantation
2. Immunotherapy of AML: Future directions
3. Selective removal of alloreactive cells from haemopoietic stem cell grafts: Graft engineering for GVHD prophylaxis
4. The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia
5. Specific depletion of graft-versus-host potential from T cells: Immunomagnetic versus immunotoxin strategies
6. Specific elimination of alloreactive T cells by an anti-interleukin-2 receptor B chain-specific immunotoxin
7. Depletion of alloreactive T cells by a specific anti-interleukin-2 receptor p55 chain immunotoxin does not impair in vitro antileukemia and antiviral activity
8. Clinical trials with an anti-CD25 ricin A-chain experimental and immunotoxin (RTF5-SMPT-dgA) in Hodgkin's lymphoma
9. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immuno-deficiency: A European retrospective study of 116 patients
10. CAMPATH-1M T-cell depleted bone marrow transplantation for severe combined immunodeficiency: Long term follow-up of 19 children treated -98 in a single center
11. In vitro T-cell depletion using Campath 1M for mismatched BMT for severe combined immunodeficiency (SCID)